MORE Health Inc.

MORE Health Inc. is a US-based company that enhances healthcare access through patient advocacy, employee benefits, and medical travel solutions. Their services aim to empower individuals and healthcare providers in informed decision-making. Founded in 2011 in San Mateo, California, MORE Health Inc.

focuses on providing comprehensive healthcare solutions. The company was recognized for its innovative approach and has engaged in three deals, with the most recent being a Series B round in August 2018, raising USD 20. 00 mn from Creadev. Hope Lewis serves as the CEO, leading a team that includes co-founders Ana Ruiz, Anna Krysiukiewicz-Fenger, and Bo Hu.

MORE Health specializes in patient advocacy, employee benefits, medical travel, and hospital solutions, offering services that enhance healthcare access and decision-making for individuals and healthcare systems globally. Their core offerings include expert second medical opinions for patients with serious illnesses, facilitating comprehensive healthcare benefits for employers, and providing user-friendly technology solutions for hospitals looking to expand their international reach. Their diverse clientele ranges from individuals seeking medical guidance to employers integrating health benefits and hospitals aiming for improved patient engagement. MORE Health's revenue model is based on partnerships and service agreements with employers and healthcare institutions.

Transactions typically involve subscription-based access to their expert medical opinion services and employee benefit offerings. Employers may engage MORE Health to provide tailored benefits packages that include second medical opinion consultations and medical travel arrangements for a fixed fee. Healthcare facilities can also access innovative solutions for reaching international patients, establishing contracts that enhance their service offerings, thereby reflecting MORE Health’s commitment to delivering value-added services. In August 2018, MORE Health Inc.

raised USD 20. 00 mn in Series B funding, with plans to utilize this capital to support the expansion of their services and reach new markets. The company aims to introduce new technology solutions designed to further streamline healthcare access and improve patient engagement. Specific targeted markets for expansion include Europe and Asia, with plans to establish a stronger presence in these regions by 2023.